32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer

NCT00346281 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

pSiMedica Limited

Collaborators